Company: GVH
Filing Date: 2025-06-27
Form Type: 424B4
Source: 0001213900-25-058674
Chunk: 43

Company: Globavend Holdings Ltd
Filing Date: 2025-06-27
Form: 424B4
Chunk 43
---
. If we receive a letter from Nasdaq indicating
that we are not compliant with the Low Priced Stock Rule, we may timely request a hearing before a Hearings Panel to appeal the delisting
determination, which would stay the delisting and suspension of our Ordinary Shares pending the decision of the Hearings Panel. No assurances
may be made as to whether our effectuation of a reverse stock would cure any future deficiencies regarding the price of our Ordinary Shares
for purposes of the Low Priced Stock Rule.

<div align='center'>14</div>

This offering may result in an immediate trading halt or delisting of our Ordinary Shares from The Nasdaq Capital Market due to public interest concerns.

Under Nasdaq Listing Rule 5101, The Nasdaq Stock Market has broad
discretionary authority to terminate the listing of securities, subject to a timely-requested hearing, if it determines that continued
listing is not in the public interest, even if the issuer is in compliance with The Nasdaq Stock Market’s enumerated listing criteria.
The Series A Warrants and Series B Warrants contain exercise price reset provisions that may result in a downward adjustment
to the exercise price, subject to a floor price. As a result of such features, the price of our Ordinary Shares issuable upon exercise
of the Series A Warrants and Series B warrants may be substantially below the then existing market price. Further, if the holders
of the Series B Warrants elect the “zero exercise price” option, the maximum number of Ordinary Shares issuable upon
exercise of the Series B Warrants will equal to the product of (a) the number of shares that would be issuable upon exercise
of the Series B Warrant in accordance with the terms of such warrant if such exercise were by means of a cash exercise rather than
a cashless exercise and (b) the quotient obtained by dividing (i) the exercise price minus the Low Price by (ii) 50% of
the Low Price, resulting in a maximum of 322,113,130 Ordinary Shares issuable upon the exercise of the Series B Warrants (assuming
the exercise price is reduced to the Floor Price). If The Nasdaq Stock Market determines the terms of this offering raise public interest
concerns due to the dilutive nature of the transaction, or any other reason, The Nasdaq Stock Market may issue a determination letter
to delist our Ordinary Shares pursuant to its discretionary authority under Listing Rule 5101. In that event, even if we